Alimera Sciences, Inc. is a biopharmaceutical company based in Alpharetta, Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals.Their main focus is on diseases affecting the back of the eye, or retina.. History. Alimera was founded in June 2003 by Dan Myers, Daniel White, Dave Holland and Mark Testerman. Alimera Sciences, Inc. (ALIM) stock forum & discussion ... Find the latest Alimera Sciences, Inc. (ALIM) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ALIMERA SCIENCES, INC. : ALIM Stock Price | MarketScreener Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through U.S. and International segment. The Company focuses on diseases affecting the back of the ALIM Institutional Ownership - Alimera Sciences, Inc. Stock Alimera Sciences Sees Hammer Chart Pattern: Time to Buy? 06-04 zacks.com - 2 Alimera Sciences, Inc. (ALIM - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because ALIM recently saw a Hammer Chart Pattern …
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. Safe(er) Stock in category See ALIM - Stock quote for ALIMERA SCIENCES, INC. - MSN Money
Alimera Sciences, Inc. (ALIM) Stock Forum & Discussion ... Find the latest Alimera Sciences, Inc. (ALIM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ALIM | Alimera Sciences Inc. Stock Price & News - WSJ View the latest Alimera Sciences Inc. (ALIM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Alimera Sciences, Inc. Common Stock (ALIM) Historical Data ... Find the latest historical data for Alimera Sciences, Inc. Common Stock (ALIM) at Nasdaq.com. ALIM:NASDAQ GM Stock Quote - Alimera Sciences Inc ...
ALIM | Alimera Sciences Inc. Analyst Estimates | MarketWatch Nov 08, 2019 · Alimera Sciences Inc. analyst estimates by MarketWatch. View ALIM revenue estimates and earnings estimates, as well as analyst recommendations. ALIM Stock Quote - Alimera Sciences, Inc. Common Stock ... Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera was incorporated on June 4, 2003 under the laws of the State of Delaware.
Learn about ALIM with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on ALIM. Stock Summary - TD Ameritrade Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through U.S. and International segment. The Company focuses on diseases affecting the back of … ALIM Stock Quote of Alimera Sciences Inc Alimera is a risky penny stock with upside potential, provided management continues reporting quarterly revenue growth. For now, then, Alimera stock looks like a buy. Alimera Sciences Reports Record Fourth Quarter and 2019 ...